<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9500169</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20475</journal-id>
<journal-id journal-id-type="nlm-ta">Neurobiol Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurobiol. Dis.</journal-id>
<journal-title-group>
<journal-title>Neurobiology of disease</journal-title>
</journal-title-group>
<issn pub-type="ppub">0969-9961</issn>
<issn pub-type="epub">1095-953X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26921468</article-id>
<article-id pub-id-type="pmc">4860088</article-id>
<article-id pub-id-type="doi">10.1016/j.nbd.2016.02.017</article-id>
<article-id pub-id-type="manuscript">NIHMS768314</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Altered Cholesterol Biosynthesis Causes Precocious Neurogenesis in the Developing Mouse Forebrain</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Driver</surname>
<given-names>Ashley M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kratz</surname>
<given-names>Lisa E.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kelley</surname>
<given-names>Richard I.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stottmann</surname>
<given-names>Rolf W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA</aff>
<aff id="A2"><label>2</label>Kennedy Krieger Institute, Johns Hopkins University, Baltimore, MD 21205, USA</aff>
<aff id="A3"><label>3</label>Department of Genetics &amp; Genomics, Boston Children’s Hospital, Boston, MA 02115</aff>
<aff id="A4"><label>4</label>Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA</aff>
<author-notes>
<corresp id="cor1"><label>*</label>author for correspondence, <email>rolf.stottmann@cchmc.org</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>16</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>7</month>
<year>2017</year>
</pub-date>
<volume>91</volume>
<fpage>69</fpage>
<lpage>82</lpage>
<!--elocation-id from pubmed: 10.1016/j.nbd.2016.02.017-->
<abstract>
<p id="P1">We previously reported a mutation in the cholesterol biosynthesis gene, <italic>hydroxysteroid (17-beta) dehydrogenase 7 (Hsd17b7<sup>rudolph</sup></italic>), that results in striking embryonic forebrain dysgenesis. Here we describe abnormal patterns of neuroprogenitor proliferation in the mutant forebrain, namely, a decrease in mitotic cells within the ventricular zone (VZ) and an increase through the remainder of the cortex by E11.5. Further evidence suggests mutant cells undergo abnormal interkinetic nuclear migration (IKNM). Furthermore, intermediate progenitors are increased at the expense of apical progenitors by E12.5, and post-mitotic neurons are expanded by E14.5. <italic>In vitro</italic> primary neuron culture further supports our model of accelerated cortical differentiation in the mutant. Combined administration of a statin and dietary cholesterol <italic>in utero</italic> achieved partial reversal of multiple developmental abnormalities in the <italic>Hsd17b7<sup>rudolph</sup></italic> embryo, including the forebrain. These results suggest that abnormally increased levels of specific cholesterol precursors in the <italic>Hsd17b7<sup>rudolph</sup></italic> embryo cause cortical dysgenesis by altering patterns of neurogenesis.</p>
</abstract>
<kwd-group>
<kwd>cortical neurogenesis</kwd>
<kwd>cholesterol biosynthesis</kwd>
<kwd>cell fate</kwd>
<kwd>neural progenitors</kwd>
<kwd>forebrain</kwd>
<kwd>neurogenesis</kwd>
<kwd>mouse</kwd>
<kwd>Hsd17b7</kwd>
<kwd>statin</kwd>
<kwd>development</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>